Related Experiment Videos
Hyponatremia risk with antidepressant use: A retrospective study
Tsung-Pi Lien1, Wen-Chun Liu2, Li-Yi Tang3
1Department of Psychiatry, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, ROC.
Journal of the Chinese Medical Association : JCMA
|July 27, 2026
Summary
This study found no significant difference in hyponatremia risk among agomelatine, escitalopram, venlafaxine, and mirtazapine after adjusting for other factors. Older age and certain comorbidities increased hyponatremia risk.
Area of Science:
- Pharmacology
- Clinical Medicine
- Neuroscience
Background:
- Selective serotonin reuptake inhibitors (SSRIs) are linked to increased hyponatremia risk.
- Mirtazapine shows a lower risk, but data on newer antidepressants like agomelatine is limited.
Purpose of the Study:
- To compare the risk of hyponatremia associated with agomelatine versus mirtazapine, escitalopram, and venlafaxine.
- To evaluate the safety profile of agomelatine concerning hyponatremia.
Main Methods:
- Retrospective cohort study using electronic medical records.
- Included antidepressant-naïve patients on monotherapy (agomelatine, escitalopram, venlafaxine, mirtazapine).
- Used multivariable logistic regression to analyze hyponatremia risk, adjusting for covariates.
Main Results:
- Incidence rates of hyponatremia varied: mirtazapine (5.8%), agomelatine (6.9%), escitalopram (8.5%), venlafaxine (10.2%).
- Univariate analysis showed higher risk with venlafaxine vs. mirtazapine.
- Adjusted analysis revealed no significant difference in hyponatremia risk among the studied antidepressants.
- Independent predictors included older age, malignancy, diabetes mellitus, and concurrent anticancer agent use.
Conclusions:
- Hyponatremia etiology is complex, influenced by patient factors beyond antidepressant choice.
- Individualized treatment strategies considering comorbidities and drug interactions are crucial.
- Further research may clarify nuanced risks of newer antidepressants.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...